The inflammatory response after cardiac surgery

Middle East Journal of Anesthesiology

Volumn 17, Issue 2, 2003, Pages 233-254

  Dabbous, Aliya ^a   Kassas, Chadi ^a   Baraka, Anis ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APROTININ; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CORTICOSTEROID; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN DERIVATIVE; PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTERY THROMBOSIS; BLOOD CLOTTING DISORDER; BRAIN DYSFUNCTION; CARDIOVASCULAR RISK; CELL ADHESION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; EXTRACORPOREAL CIRCULATION; FIBRINOGEN GENE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GRAFT OCCLUSION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; INFLAMMATION; KIDNEY FAILURE; LUNG INJURY; MINIMALLY INVASIVE CARDIAC SURGERY; MORBIDITY; MORTALITY; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; POTASSIUM CHANNEL; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; STROKE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM; ADULT RESPIRATORY DISTRESS SYNDROME; CARDIOPULMONARY BYPASS; PHYSIOLOGY; REVIEW;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CYTOKINES; HUMANS; INFLAMMATION; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; REPERFUSION INJURY; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0642336286     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. ROYSTON D, BIDSTRUP BP, TAYLORKM, SAPSFORD RN: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2:1289-91, 1987.
2. HUMPHRIES SE, YE S, TALMUD P, ET AL: European atherosclerosis research study: Genotype at the fibrinogen locus (G455-beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 15:96-104, 1995.
3. MAURIELLO A, SANGIORGI G, PALMIERI G, ET AL: Hyperfibrinogemia is associated with specific histological composition and complications of therosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 101:744-50, 2000.
4. VAN DER BOM JG, DE KNIJFF P, HAVERKATE F, ET AL: Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 95:2623-7, 1997.
5. BENZA RL, GRENETT HE, BOURGE RC, ET AL: Gene polymorphism for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease. Circulation 98:2248-54, 1998.
6. ERIKSSON P, KALLIN B, VAN'T HOOFT FM, ET AL: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-5, 1995.
7. RIFON J, PARAMO JA, PANIZO C, ET AL: The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery. Br J Haematol 99:262-7, 1997.
8. DAHLBACK B: The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 77:1-43, 1995.
9. DAHLBACK B: Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulopathy by dual mechanisms. J Lab Clin Med 133:415-22, 1999.
10. KARDIA SL, HVILAND MB, FERRELL RE, SING CF: The relationship between the risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype. Arterioscler thromb Vasc Biol 19:427-35, 1999.
11. ROSENDAAL FR, DOGGEN CJ, ZIVELIN A ET AL: Geographic distribution of the G20210 A prothrombin variant. Thromb Haemost 79:706-8, 1998.
12. ROACH GW, KANCHUDER M, MANGANO CM ET AL: Adverse cerebral outcomes after coronary artery bypass. N Engl J Med 335:1857-63, 1996.
13. TUMAN KJ, MCCARTHY RJ, NAJAFI H, IVANKOVICH AD: Differential effects of advanced age on neurologic and cardiac risks of coronary operations. J Thorac Cardiovasc Surg 104:1510-7, 1992.
14. SPIESS BD, LEY C, BODY SC, ET AL: Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 116:460-7, 1998.
15. ARONSON S, BLUMENTHAL R: Perioperative renal dysfunction after cardiovascular anesthesia: concerns and controversies. J Cardiothorac Anaesth 13:567-86, 1998.
16. AVALL A, HYLLNER M, BENGTSON JP ET AL: Postoperative inflammatory response after autologus and allogeneic blood transfusion. Anesthesiology 87(3):511-6, 1997.
17. LEVY JH, PIFARRE R, SCHAFF HV, ET AL: A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92:2236-44, 1995.
18. MILLER BE, LEVY JH: The inflammatory response to cardiopulmonary bypass. Cardiothorac Vasc Anaesthesia 11:355-66, 1997.
19. CHENOWETH DE, COOPER SW, HUGLI TE ET AL: Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304:497-503, 1981.
20. KHABAR KSA, ELBARBARY MA, KHOUQEER F, ET AL: Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunology Immunopath 85(1):97-103, 1997.
21. GILLILAND HE, ARMSTRONG MA, MCMURRAY TJ: The inflammatory response to pediatric cardiac surgery: correlation of granulocyte adhesion molecule expression with postoperative oxygenation. Anaesth Analg 89:1188-91, 1999.
22. LAZENBY WD, WILSON K, ZELANO JA, LEBOWITZ N, SHIN WT, ISOM OW, KRIEGER KH: Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass. Ann Thorac Surg 53:957-64, 1992.
23. OHRI SK, BJARNASON I, PATHI V, ET AL: Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 55:1080-6, 1993.
24. ANDERSEN LW, BAEK L, DEGN H, LEDH J, RASMUSSEN JP: Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93:115-9, 1987.
25. JANSEN NJG, VAN OEVEREN W, GU YG ET AL: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744-48, 1992.
26. WAN S, LECLERC JL, VINCENT JL: Inflammatory response to cardiopulmonary bypass. Chest 112:676-92, 1997.
27. JEAN D, REZAIGUIA-DELCLAUX S, DELACOURAT C ET AL: Protective effect of endotoxin instillation on subsequent bacteria-induced acute lung injury in rats. Am J Respir Crit Care Med 158:1702-8, 1998.
28. VAN LEEUWEN PA, BOERMEESTER MA ET AL: Clinical significance of translocation. Gut 35:828-34, 1994.
29. HUBNER G, BRAUCHLE M ET AL: Differential regulation of proinflammatory cytokines during wound healing in normal and glucocorticoid treated mice. Cytokine 8:548-56, 1996.
30. OGLE CK, GUO X ET AL: Induction of endotoxin tolerance in rat bone marrow cells by in-vivo infusion of tumor necrosis factor. Crit Care Med 25:827-33, 1997.
31. BROWN JM, WHITE CW ET AL: Interleukin 1 pretreatment decreases ischemia/reperfusion. Proc Natl Acad Sci USA 87:5026-30, 1990.
32. ROSENBERG RD, AIRD WC: Vascular bed specific hemostasis and hypercoagulable states. New Engl J. Med 340:1555-64, 1999.
33. ASIMAKOPOULOS G, SMITH PL, RATNATUNGA CP, TAYLOR KM: Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 66:2135-44, 1998.
34. ROYSTON D, FLEMING JS, DESAI JB, WESTABY S, TAYLOR KM: Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg 91:759-66, 1986.
35. KIM KB, CHUNG HH, KIM MS, RHO JR: Changes in the antioxidative defensive system during open heart operations in humans. Ann Thorac Surg 58:170-5, 1994.
36. PARK JL, LUCCHESI BR: Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68:1905-12, 1999.
37. HOMEISTER JW, SATHO P, LUCCHESI BR: Effects of complement activation in the isolated heart. Role of the terminal complement component. Circ Res 71:303-19, 1992.
38. DOWNEY JM, COHEN MV, YTREHUS K, LIU Y: Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann N Y Acad Sci 723:82-98, 1994.
39. BRASIL LA, GOMES WJ ET AL: Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 66:56-9, 1998.
40. MATATA BM, SOSNOWSKI AW ET AL: Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 69:785-91, 2000.
41. STRUBER M, CREMER JT ET AL: Human cytokine responses to coronary artery bypass frafting with or without cardiopulmonary bypass. Ann Thorac Surg 68:1330-5, 1999.
42. ASCIONE R, LLOYD CT ET AL: On pump versus off pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 68:493-8, 1999.
43. WAN S, IZZAT MB ET AL: Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 68:52-6, 1999.
44. DIEGELER A, DOLL N ET AL: Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique and conventional cardiopulmonary bypass. Circulation 102:III95-100, 2000.
45. GU YG, MARIANI MA ET AL: Reduction of inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 65:420-4, 1998.
46. ASCIONE R, LLOYD CT ET AL: Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69:1198-204, 2000.
47. GOX CM, ASCIONER R, ET AL: Effect of cardiopulmonary bypass on pulmonary gas exchange: A prospective randomized study. Ann Thorac Surg 69:140-5, 2000.
48. GAMOSO MG, PHILLIPS-BUTE B, ET AL: Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Aesth Anelg 91:180-4, 2000.
49. DUHAYLONGSOD FG: Minimally invasive cardiac surgery defined. Arch Surg 135:296-301, 2000.
50. HALL RI, SMITH RS, ROCKER G: The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, theurapeutic, and pharmacological considerations. Anesth Analg 85:766-82, 1997.
51. OVRUM E, MOLLNES TE, FOSSE E, ET AL: Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 110:1623-32, 1995.
52. ENGELMAN RM, ROUSOU JA, FLACK JE, DEATION DW, KALFIN R, DAS DK: Influences of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 60:801-4, 1995.
53. ROYSTON D: Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors. Int J Cardiol 53:S11-S37, 1996.
54. COGHLAN JG, FLITTER WD, CLUTTON SM, ET AL: Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 107:248-56, 1994.
55. AMBROSIO G, JACOBUS WE, BERGMAN CA, WEISMAN HF, BECKER LC: Preserved high energy phosphate metabolic reserve in globally stunned heart despite reduction of basal ATP content and contractility. J Mol Cell Cardiol 19:953-64, 1987.
56. KAWAMURA T, INADA K, OKADA H, ET AL: Methylprednisolone inhibit increase of interleukin 8 and 6 during open heart surgery. Can J Anaesth 42:399-403, 1995.
57. TABARDEL Y, DUCHATEAU J, SCHMATZ D, ET AL: Corticosteroids increase blood interleukin 10 levels during cardiopulmonary bypass in men. Surgery 119:76-80, 1996.
58. LEVI M, CROMHEECKE ME, DE JONGE E, ET AL: Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:19940-7, 1999.
59. GOTT JP, COOPER WA, SCHMIDT FEJ, ET AL: Modifying risk of extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg 66:747-53, 1998.
60. SUNAMORI M, SUZUKI A: Improved efficacy of intra-aortic balloon pumping by pharmacological myocardial protection for postoperative pump failure after coronary revascularization. Jpn J Surg 18:61-7, 1988.
61. FITCH JC, ROLLINS S, ET AL: Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 compliment inhibitor in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. Circulation. 100:2499-506, 1999.
62. ROYTBLAT L, ROY-SHAPIRA A, GREENBERG L ET AL: Ketamine and IL-6 response after CPB. Anaesth analg 87:266-71, 1998.
63. HILL GE, ANDERSON JL, LYDEN ER: Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular camp accumulation. Anesth Anagl 87:1015-19, 1998.
64. KEROTEN JR, SCHMELING TJ, PAGEL PS, ET AL: Isoflurance mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87:361-70, 1997.